<- Go Home
Soliton, Inc.
Soliton, Inc., a medical device company, develops and commercializes products using a proprietary rapid acoustic pulse technology platform. The company offers products for the removal of tattoos. It also develops a product for cellulite reduction, fibrotic scar treatment, and other indications. The company was incorporated in 2012 and is based in Houston, Texas. Soliton, Inc. operates as a subsidiary of AbbVie Inc.
Market Cap
$487.6M
Volume
348.3K
Cash and Equivalents
$21.7M
EBITDA
-$23.2M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$26.0K
Profit Margin
7.03%
52 Week High
$22.60
52 Week Low
$7.40
Dividend
N/A
Price / Book Value
22.82
Price / Earnings
-26.88
Price / Tangible Book Value
23.17
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
-$23.8M
Return on Equity
63.97%
Return on Assets
-47.56
Cash and Short Term Investments
$21.7M
Debt
N/A
Equity
$21.4M
Revenue
$370.0K
Unlevered FCF
-$10.1M
Sector
Health Care Equipment and Supplies
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium